Vijaya Diagnostic Centre Limited Stock

Equities

VIJAYA

INE043W01024

Healthcare Facilities & Services

Market Closed - NSE India S.E. 07:43:49 2024-04-26 EDT 5-day change 1st Jan Change
702.9 INR +1.66% Intraday chart for Vijaya Diagnostic Centre Limited +4.47% +4.03%

Financials

Sales 2024 * 5.42B 65.03M 88.91M Sales 2025 * 6.66B 79.82M 109M Capitalization 71.94B 863M 1.18B
Net income 2024 * 1.18B 14.14M 19.33M Net income 2025 * 1.47B 17.67M 24.15M EV / Sales 2024 * 12.9 x
Net cash position 2024 * 1.91B 22.88M 31.29M Net cash position 2025 * 3.04B 36.45M 49.83M EV / Sales 2025 * 10.4 x
P/E ratio 2024 *
60.9 x
P/E ratio 2025 *
49 x
Employees 1,996
Yield 2024 *
0.22%
Yield 2025 *
0.23%
Free-Float 45.15%
More Fundamentals * Assessed data
Dynamic Chart
Vijaya Diagnostic Centre's Consolidated Profit Jumps in Fiscal Q3 MT
Transcript : Vijaya Diagnostic Centre Limited, Q3 2024 Earnings Call, Feb 06, 2024
Vijaya Diagnostic Centre Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Vijaya Diagnostic Centre Completes Acquisition of PH Diagnostic MT
Transcript : P H Diagnostic Centre Private Limited, Vijaya Diagnostic Centre Limited - M&A Call
Vijaya Diagnostic Centre Limited completed the acquisition of P H Diagnostic Centre Private Limited. CI
Vijaya Diagnostic Centre to Acquire P H Diagnostic Centre for INR1.4 Billion MT
Vijaya Diagnostic Centre Limited entered into Share Purchase agreement to acquire P H Diagnostic Centre Private Limited for INR 1.3 billion. CI
Correction: Vijaya Diagnostic Centre's Consolidated Profit Jumps in Fiscal Q2; EPS, Revenue Top Estimates MT
Vijaya Diagnostic Centre Seeks M&A CI
Transcript : Vijaya Diagnostic Centre Limited, Q2 2024 Earnings Call, Nov 08, 2023
Vijaya Diagnostic Centre Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Vijaya Diagnostic Centre Limited Appoints Sura Suprita Reddy as Managing Director CI
Vijaya Diagnostic Centre Limited Appoints Sura Suprita Reddy as Chief Executive Officer CI
Vijaya Diagnostic Centre Limited Proposes Final Dividend for the Financial Year Ended March 31, 2023 CI
More news
1 day+1.66%
1 week+4.47%
Current month+10.41%
1 month+10.55%
3 months+8.47%
6 months+29.82%
Current year+4.03%
More quotes
1 week
652.45
Extreme 652.45
720.00
1 month
629.95
Extreme 629.95
720.00
Current year
596.05
Extreme 596.05
720.00
1 year
360.00
Extreme 360
720.00
3 years
295.00
Extreme 295
720.00
5 years
295.00
Extreme 295
720.00
10 years
295.00
Extreme 295
720.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 42 02-06-04
Director of Finance/CFO - 21-04-30
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member 57 21-05-25
Founder 75 80-12-31
Director/Board Member 48 02-06-04
More insiders
Date Price Change Volume
24-04-26 702.9 +1.66% 178,710
24-04-25 691.4 +2.88% 94,852
24-04-24 672 +1.72% 52,216
24-04-23 660.7 -1.06% 158,421
24-04-22 667.8 -0.76% 95,075

Delayed Quote NSE India S.E., April 26, 2024 at 07:43 am

More quotes
Vijaya Diagnostic Centre Limited is an India-based company. The Company is engaged in the business of providing a range of diagnostic services spanning pathological investigations, basic and high-end radiology, nuclear medicine and related healthcare services. The Company operates through the Diagnostic Services segment. Its test menu includes pathology tests ranging from basic biochemistry and clinical pathology to cytogenetics and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests, including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans, single photon emission computed tomography (SPECT) and advanced positron emission tomography CT (PET CT). The Company also offers a range of health and wellness packages to its customers as per their requirements. It operates approximately 121 diagnostic centers and 17 reference laboratories in 20 cities spread across India.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
702.9 INR
Average target price
678.6 INR
Spread / Average Target
-3.46%
Consensus
  1. Stock Market
  2. Equities
  3. VIJAYA Stock